Cargando…
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial
BACKGROUND: Previous studies have investigated the protective effect of vitamin D serum levels, at diagnosis and during the follow-up period after treatment, on melanoma outcome. In the present study we assess whether vitamin D supplementation, in the follow-up period after diagnosis and surgical re...
Autores principales: | De Smedt, J., Van Kelst, S., Boecxstaens, V., Stas, M., Bogaerts, K., Vanderschueren, D., Aura, C., Vandenberghe, K., Lambrechts, D., Wolter, P., Bechter, O., Nikkels, A., Strobbe, T., Emri, G., Marasigan, V., Garmyn, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569491/ https://www.ncbi.nlm.nih.gov/pubmed/28835228 http://dx.doi.org/10.1186/s12885-017-3538-4 |
Ejemplares similares
-
Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population
por: DE SMEDT, Julie, et al.
Publicado: (2022) -
Analysis of DME/DME Navigation Performance and Ground Network Using Stretched-Front-Leg Pulse-Based DME
por: Kim, Euiho
Publicado: (2018) -
Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies
por: Midena, Edoardo, et al.
Publicado: (2018) -
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies
por: Staurenghi, Giovanni, et al.
Publicado: (2018) -
Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic
por: Brochez, L., et al.
Publicado: (2020)